Prague welcomes new biotech and biomedical research centre

The Czech Academy of Science’s Institute of Molecular Genetics is leading a consortium to set up the centre, BIOCEV, which will create some 400 new jobs.

Additional tools

Print  

The new centre will be built in Vestec village, south of the Czech capital, providing a forum for researchers and advanced postgraduate students.

Research boost for Czech Republic

BIOCEV has been designed to meet a need in the Czech Republic for a modern research centre in biomedicine and biotechnology research, and will aim to deliver results in research and development (R&D), teaching and the transfer of research results into practice. It aims to be a Centre of Excellence within the European Research Area. As such, it should benefit doctoral students, research institutions and the scientific community in the Czech Republic, as well as the wider society.

Five research programmes

The centre will focus on innovation in the fields of biotechnology and biomedicine, creating a forum where renowned specialists based in different locations can meet to form research teams based on their mutual interests. The aim is to achieve maximum synergy between basic research and research with high applicability and application potential.

It will run five scientific research programmes: functional genomics; cell biology and virology; structural biology and protein engineering; biomaterials and cell tissue engineering; and development of therapeutic and diagnostic procedures.

The consortium of seven partners involved in establishing the centre will be led by the Czech Academy of Sciences’ Institute of Molecular Genetics, the project beneficiary. Other partners include five other institutes at the Academy of Sciences and the faculties of science and of medicine of Charles University in Prague.

State of the art research centre

The building project will commence in mid-2012 and is due to be completed two years later. It will comprise new buildings to house laboratories kitted out with state-of-the-art technologies and equipment. There will be five central service laboratories and 54 research labs in the new premises, which will measure 25 483 m2 in total. Twenty-four technological modules will be provided to meet the requirements of the five research programmes. It is expected that 450 researchers and 250 postgraduate students will use the centre.

Some 400 new R&D jobs are expected to be created thanks to the new centre, which will support some 10 collaborative applied research projects .

Total and EU funding

The project “Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec – BIOCEV” has total eligible costs for funding of EUR 98 005 364, of which the EU’s European Regional Development Fund is contributing EUR 83 304 560 during the programming period 2007-2013.

Draft date

04/06/2012